Sorry, you need to enable JavaScript to visit this website.

XALACOM (latanoprost and timolol ophthalmic solution (as timolol maleate) Contraindications

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Contraindications

XALACOM (latanoprost and timolol maleate) is contraindicated in patients with:

  • reactive airway disease including bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease.
  • sinus bradycardia, sick sinus syndrome, sino-atrial block, second or third degree atrioventricular block not controlled with pace-maker, overt cardiac failure, or cardiogenic shock.
  • known hypersensitivity to latanoprost, timolol, benzalkonium chloride or any other ingredient in the product. For a complete listing, see the DOSAGE FORMS, COMPOSITION and PACKAGING section of the product monograph.

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111